Cancer Chemotherapy and Biotherapy
Principles and Practice
2nd Edition
Published on 27. August 2001
Book
Hardback
1152 pages
978-0-7817-2269-8 (ISBN)
Description
Thoroughly revised and updated, this book presents a comprehensive, detailed description of the properties and clinical use of anticancer drugs. It provides the latest information on all currently available drugs and biologic agents - their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Particular emphasis is placed on the rationale for the use of drugs in specific schedules and combinations, and guidelines are provided for dose adjustment in particular situations. This edition includes new chapters on pharmacology of CNS agents; cancer vaccines; inhibitors of tumor angiogenesis; bisphotphonates; and strategies for drug discovery. This is a Brandon-Hill recommended title.
Thoroughly revised and updated, this book presents a comprehensive, detailed description of the properties and clinical use of anticancer drugs. It provides the latest information on all currently available drugs and biologic agents - their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Particular emphasis is placed on the rationale for the use of drugs in specific schedules and combinations, and guidelines are provided for dose adjustment in particular situations. This edition includes new chapters on pharmacology of CNS agents; cancer vaccines; inhibitors of tumor angiogenesis; bisphotphonates; and strategies for drug discovery. This is a Brandon-Hill recommended title.
Thoroughly revised and updated, this book presents a comprehensive, detailed description of the properties and clinical use of anticancer drugs. It provides the latest information on all currently available drugs and biologic agents - their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Particular emphasis is placed on the rationale for the use of drugs in specific schedules and combinations, and guidelines are provided for dose adjustment in particular situations. This edition includes new chapters on pharmacology of CNS agents; cancer vaccines; inhibitors of tumor angiogenesis; bisphotphonates; and strategies for drug discovery. This is a Brandon-Hill recommended title.
More details
Edition
2nd Revised edition
Language
English
Place of publication
Philadelphia
United States
Target group
College/higher education
Professional and scholarly
Edition type
Revised edition
Product notice
Cloth over boards
Illustrations
232
Dimensions
Height: 279 mm
Width: 203 mm
Weight
3175 gr
ISBN-13
978-0-7817-2269-8 (9780781722698)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Book
11/2005
4th Edition
Lippincott Williams and Wilkins
€211.31
Article exhausted; check for reprint
Previous edition
Book
12/1995
2nd Edition
Lippincott Williams and Wilkins
€135.41
Article exhausted; check for reprint
Persons
Content
Clinical Strategies for Cancer Treatment: The Role of Drugs Preclinical Aspects of Cancer Drug Discovery and Development Pharmacokinetics and Clinical Monitoring Infertility after Cancer Chemotherapy Carcinogenesis: A Late Complication of Cancer Chemotherapy Steroid Hormone Therapies for Cancer Antifolates 5-Fluoropyrimidines Cytidine Analogs Purine Antimetabolites Hydroxyurea Antimicrotubule Agents Alkylating Agents Nonclassic Alkylating Agents Cisplatin and Analogs Bleomycin Antitumor Antibiotics Anthracyclines and Anthracenediones Topoisomerase II Inhibitors: Epipodophyllotoxins, Acridines, Ellipticines, and Bisdioxopiperazines Topoisomerase I Targeting Agents: The Camptothecins Enzyme Therapy: l-Asparaginase Pharmacologic Considerations in Chemotherapy for Brain Tumors Retinoids and Other Differentiating Agents Bisphosphonates Radiation Modifiers Pharmacology of Interferons:Induced Proteins, Cell Activation, and Antitumor Activity Clinical Pharmacokinetics of Interleukin 1, Interleukin 2, Interleukin 4, Tumor Necrosis Factor, Interleukin 12, and Macrophage Colony-Stimulating Factor Colony-Stimulating Factors Antibody-Based Immunotherapies for Cancer Targeted Therapy Physical Barriers to Drug Delivery Adoptive Cellular Therapy Cancer Vaccines Cytokine and Growth Factor and Receptor Database: Biologic, Molecular, and Pathophysiologic Properties of Ligand-Receptor Interactions Inhibitors of Tumor Angiogenesis Pharmacogenetics Chemokine-Chemokine Receptor Database 2001: Biologic, Molecular, and Pathophysiologic Properties of Chemokine-Receptor Interactions Index